Insights into the SFB Conference in San Diego, USA, April 19-22, 2023
Fitting the theme ‘Riding the Translational Waves to the Future’ for the SFB 2023 Annual Meeting, we are so happy to have been a part of a thought-provoking and engaging panel conversation around the translational aspects of 3D and 4D printing and bioprinting. With leading co-panelists, providing insights into the clinician, regulatory and funding perspectives, our Applications and Innovation Manager, Eva Mueller, spoke on behalf of Brinter and shared valuable perspectives from the bioprinting industry.
It was a fantastic experience learning from the fellow co-panelists and the engaged audience participants and sharing our combined vision for the future of 3D bioprinting from different perspectives. One valuable lesson from our discussion revolved around multi-disciplinary collaborations and the importance of partnerships to advance our technologies to industrial production and clinical translation.
Eva Mueller, PhD, Applications and Innovation Manager
SFB is held every year, and brings together researchers, scientists, clinicians, trainees and students from both academia and industry to discuss critical developments in the field. The theme of this year’s SFB meeting is ‘Riding the Translational Waves to the Future’, and the program is focused on breakthroughs in biomaterials science, translation of research to clinical application, next-generation medical devices, standards development, regulatory issues, and commercial realities. The meeting is led by keynote speakers each day, consists of technical sessions and poster presentations, and an interactive exhibit hall with leading companies in the field of biomaterials. For additional information, please visit: https://2023.biomaterials.org/